Evidence map›Paper›PMID 36550321›Full record

ArticleNature immunology2023

Staphylococcal phosphatidylglycerol antigens activate human T cells via CD1a.

Gwennaëlle C Monnot, Marcin Wegrecki, Tan-Yun Cheng, Yi-Ling Chen, Brigitte N Sallee, Reka Chakravarthy, Ioanna Maria Karantza, Shin Yi Tin, Alexandra E Khaleel, Isha Monga and 15 more

Open access · greenAbstract read
In one paragraph

Article in Nature immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. T-cell mechanisms in atopic dermatitis.Allergologie select · 2026
    Review
  5. Article
  6. Article
  7. CD1a and Lipids as Mediators of T Cell Activation in the Skin.The Journal of investigative dermatology · 2025
    Review
  8. Metabolites · 2025
    Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. CD1a and skin T cells: a pathway for therapeutic intervention.Clinical and experimental dermatology · 2024
    Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. CD1 displays its own negative regulators.Current opinion in immunology · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 4 institutions in 3 countries.

Gwennaëlle C MonnotDepartment of Dermatology, Columbia University Irving Medical Center, New York, NY, USA.ORCID http://orcid.org/0000-0003-1084-3450
Marcin WegreckiInfection and Immunity Program and Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia.ORCID http://orcid.org/0000-0002-3275-9850
Tan-Yun ChengDivision of Rheumatology, Inflammation and Immunity, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Yi-Ling ChenMedical Research Council Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0003-3758-0638
Brigitte N SalleeDepartment of Dermatology, Columbia University Irving Medical Center, New York, NY, USA.
Reka ChakravarthyDepartment of Dermatology, Columbia University Irving Medical Center, New York, NY, USA.
Ioanna Maria KarantzaDepartment of Dermatology, Columbia University Irving Medical Center, New York, NY, USA.
Shin Yi TinInfection and Immunity Program and Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia.
Alexandra E KhaleelDepartment of Dermatology, Columbia University Irving Medical Center, New York, NY, USA.
Isha MongaDepartment of Dermatology, Columbia University Irving Medical Center, New York, NY, USA.ORCID http://orcid.org/0000-0002-4683-9456
Laura N UwakweDepartment of Dermatology, Columbia University Irving Medical Center, New York, NY, USA.
Alice TillmanDepartment of Medicine, Columbia University Irving Medical Center, New York, NY, USA.
Bin ChengDepartment of Biostatistics, Columbia University Irving Medical Center, New York, NY, USA.
Soundos YoussefDepartment of Dermatology, Columbia University Irving Medical Center, New York, NY, USA.ORCID http://orcid.org/0000-0002-1345-324X
Soo Weei NgMedical Research Council Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
Adam ShahineInfection and Immunity Program and Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia.ORCID http://orcid.org/0000-0001-7717-4437
Javier A Garcia-VilasDepartment of Medicine, Columbia University Irving Medical Center, New York, NY, USA.
Anne-Catrin UhlemannDepartment of Medicine, Columbia University Irving Medical Center, New York, NY, USA.ORCID http://orcid.org/0000-0002-9798-4768
Lindsey A BordoneDepartment of Dermatology, Columbia University Irving Medical Center, New York, NY, USA.
Arnold HanDepartment of Medicine, Columbia University Irving Medical Center, New York, NY, USA.
Christine H RohdeDepartment of Surgery, Columbia University Irving Medical Center, New York, NY, USA.
Graham OggMedical Research Council Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0002-3097-045X
D Branch Moody *Division of Rheumatology, Inflammation and Immunity, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0003-2306-3058
Jamie Rossjohn *Infection and Immunity Program and Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia.ORCID http://orcid.org/0000-0002-2020-7522
Annemieke de Jong *Department of Dermatology, Columbia University Irving Medical Center, New York, NY, USA. ad2952@cumc.columbia.edu.ORCID http://orcid.org/0000-0001-6707-6585
Columbia University Irving Medical Center · USAustralian Regenerative Medicine Institute · AUUniversity of Oxford · GBBrigham and Women's Hospital · US

Funding

Tumor Biology and Microenvironment ProgramP30CA013696 · NCI · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI Anil K Rustgi · 1985 to 2026
$115.3M
Clinical and Translational Science AwardUL1TR001873 · NCATS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI REILLY, MUREDACH P · 2016 to 2025
$99.0M
T cell response to CDI-restricted lipids in tuberculosisR01AI049313 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI MOODY, DAVID BRANCH · 2001 to 2025
$10.6M
CD1 Presentation of Self Lipids to Human T CellsR01AR048632 · NIAMS · BRIGHAM AND WOMEN'S HOSPITAL · PI MOODY, DAVID BRANCH · 2002 to 2024
$9.4M
Translational and Precision Medicine Resources Core (TRAP)P30AR069632 · NIAMS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI BICKERS, DAVID RINSEY · 2016 to 2020
$3.9M
Role of secreted phospholipase A2 in the activation of human CD1-restricted T cellsR01AR074037 · NIAMS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI DE JONG, ANNEMIEKE · 2019 to 2024
$1.7M
CD1 autoreactive T cells in human inflammatory skin diseaseR37AR048632 · NIAMS · BRIGHAM AND WOMEN'S HOSPITAL · PI DAVID Branch MOODY · 2025 to 2026
$1.1M
BD Biosciences InfluxS10OD020056 · OD · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI SNOECK, HANS-WILLEM E · 2015 to 2015
$600k
Activation of Human Skin T Cells by Mammalian and Microbial Lipids Presented by CD1aK01AR068475 · NIAMS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI DE JONG, ANNEMIEKE · 2015 to 2019
$541k
Becton Dickinson LSR II Analytical Flow CytometerS10RR027050 · NCRR · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI CLYNES, RAPHAEL A. · 2011 to 2011
$413k
Department of HealthMedical Research Council MC_UU_00008/5Medical Research Council MC_UU_00036/2NCATS NIH HHS UL1 TR001873NCI NIH HHS P30 CA013696NCRR NIH HHS S10 RR027050NIAID NIH HHS R01 AI049313NIAMS NIH HHS K01 AR068475NIAMS NIH HHS P30 AR069632NIAMS NIH HHS R01 AR048632NIAMS NIH HHS R01 AR074037NIAMS NIH HHS R37 AR048632NIH HHS S10 OD020056Wellcome Trust 209222/Z/17/Z
6 · The paper itself

Abstract

Expressed on epidermal Langerhans cells, CD1a presents a range of self-lipid antigens found within the skin; however, the extent to which CD1a presents microbial ligands from bacteria colonizing the skin is unclear. Here we identified CD1a-dependent T cell responses to phosphatidylglycerol (PG), a ubiquitous bacterial membrane phospholipid, as well as to lysylPG, a modified PG, present in several Gram-positive bacteria and highly abundant in Staphylococcus aureus. The crystal structure of the CD1a-PG complex showed that the acyl chains were buried within the A'- and F'-pockets of CD1a, while the phosphoglycerol headgroup remained solvent exposed in the F'-portal and was available for T cell receptor contact. Using lysylPG and PG-loaded CD1a tetramers, we identified T cells in peripheral blood and in skin that respond to these lipids in a dose-dependent manner. Tetramer

Indexed as

Dermatitis, AtopicAntigens, CD1AutoantigensHumansLangerhans CellsPhosphatidylglycerolsSkinStaphylococcusAntigens, CD1AutoantigensPhosphatidylglycerols

Identifiers

PMID36550321
PMCPMC10389259
OpenAlexW4312114750

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.